Drugs Keep Winning in the Global War on Drugs
The United Nations’ latest World Drug Report makes that very clear.
The United Nations’ latest World Drug Report makes that very clear.
The Manhattan Institute’s Charles Fain Lehman misstates the findings of a new paper to claim he was right all along.
After upholding the Second Amendment rights of drug users and carry permit holders, the justices will address the constitutionality of "assault weapon" bans.
Joe Rogan and military veterans advocating for suicide prevention apparently swayed the president.
Aaron Brown discusses how research gets distorted, why sensational claims spread so quickly, and how to think more critically about the numbers behind the headlines.
A dispensary owner believes Hawaii’s hemp regulations are unconstitutional. He’s suing to stop their enforcement, but the law may not be on his side.
Rescheduling marijuana will make it easier to study a drug that tens of millions of Americans already use.
The Supreme Court's decision in United States v. Hemani could open the door to relief for cannabis consumers convicted of illegal gun possession.
The decision is a modest but welcome step toward rectifying the injustice of criminalizing conduct that violates no one’s rights.
Even under the Supreme Court's highly elastic understanding of that clause, Thomas says, such laws do not qualify as regulation of interstate commerce.
The conservative justice continues to wage a lonely legal crusade over the Commerce Clause.
The Supreme Court's unanimous decision in Hemani.
The unanimous decision upholding the gun rights of cannabis consumers is striking given the Supreme Court's long history of accommodating the war on drugs.
A notable 9-0 Second Amendment decision that features three concurring opinions, all of which make good points.
A landmark win for the right to keep and bear arms in United States v. Hemani.
After nearly four years of legal battles, Tayvin Galanakis has finally won his case against the officers who arrested him for allegedly driving while intoxicated without probable cause.
Federal prohibition of hemp-derived THC products would destroy a $37.5 billion industry to solve a problem states are already handling.
But many older enhanced athletes did achieve better results than their younger selves.
I watched hours and hours of the Enhanced Games so you didn’t have to.
Eli Lilly's retatrutide is a significant advance on the promising results from drugs like Ozempic and Wegovy.
A 10 percent ownership cap was supposed to prevent monopolies in Missouri's marijuana market. Instead, the state's licensing regime may have created a blueprint for companies to build one.
The new rules will fast track clinical testing, but a far cry from legalization or decriminalization.
Nominees include stories on America's gerontocracy, the war on chocolate, how Texas beat California on housing, and more.
Terminally ill patients were promised access to experimental treatments, but the "right to try" exists mostly on paper.
Plus: Ella Emhoff's SSRIs, measuring childhood independence, the hantavirus cruise ship, and more...
Plus: The NFL has no easy response to the Dianna Russini–Mike Vrabel affair, and how ketamine may have helped the Sixers upset the Celtics
The agency issued "national priority vouchers" for the two drugs six days after President Donald Trump promised to facilitate approval of psychedelic therapies.
Plus: California fails to unmask ICE agents, the illogic of medical-only marijuana rescheduling, driverless cars in D.C., and more...
Acting Attorney General Todd Blanche's distinction between medical and recreational cannabis is hard to reconcile with the relevant scientific and statutory criteria.
Plus: skyway socialism, reconsider the lobster, D.C.'s urban growth, and more...
The medical model assumes that people should be allowed to use psychedelics only for government-approved reasons.
Donald Trump is an unlikely but powerful champion of drug reform.
Plus: Scandal at the Department of Labor, the real reasons people use psychedelics, more problems with Trump's triumphal arch, and more...
Plus: Trump orders psychedelic drug research, Palantir calls for national service, and confusion surrounds Iran and the Strait of Hormuz.
The president's facilitation of research and FDA review could help make psychedelics available to approved patients. But what about everyone else?
From higher crime to teenage stoners, here are things that the weed debate got wrong.
Afroman discusses his free speech court victory, why he thinks he could unite America, and whether he feels pressure to always be high.
Plus: ship seizures, the best free bread in America, and more...
Plus: The U.S. blockade widens, Los Angeles teachers get a pay bump, the sunny side of a treeless national mall, and more...
A 2024 study estimated that 30,000 people every year may be getting wrongly arrested due to unreliable roadside drug tests used by police.
Good intentions, bad results.
As many as 30,000 people may have died at the hands of the state-sponsored death squads.
His push relies on dubious data about the pills' safety.
Plus: Kristi Noem is fired as DHS secretary, a listener asks about libertarian drug use, and new polling reveals Americans distrust AI and each other.
The death of El Mencho shows why decades of prohibition enforcement have only strengthened cartels.
The president claims that thousands of American lives are saved every time the government blows up a suspected drug boat.
A Supreme Court case illustrates the potential for trans-partisan alliances between critics of gun control and critics of the war on drugs.
Celebrate your independence with a subscription to Reason magazine, your most trusted source of honest, insightful news and analysis.